Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Thermo Fisher Scientific Inc. (TMO) had Free Cash Flow of $6.34B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$44.56B |
|
$6.70B |
|
$26.32B |
|
$18.24B |
|
$36.81B |
|
$7.75B |
|
$-438.00M |
|
$7.31B |
|
$7.31B |
|
$6.76B |
|
$6.72B |
|
$6.72B |
|
$6.76B |
|
$7.75B |
|
$10.53B |
|
377.00M |
|
378.00M |
|
$17.77 |
|
$17.74 |
|
| Balance Sheet Financials | |
$28.71B |
|
$10.56B |
|
$81.64B |
|
$110.34B |
|
$15.19B |
|
$35.85B |
|
$41.74B |
|
$56.93B |
|
$53.41B |
|
$-11.79B |
|
$53.41B |
|
376.22M |
|
| Cash Flow Statement Financials | |
$7.82B |
|
$-4.05B |
|
$1.80B |
|
$4.04B |
|
$9.88B |
|
$5.84B |
|
$310.00M |
|
$-636.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.89 |
|
-- |
|
-- |
|
0.40 |
|
0.74 |
|
40.93% |
|
17.39% |
|
17.39% |
|
23.63% |
|
16.40% |
|
15.05% |
|
|
Free Cash Flow |
$6.34B |
-- |
|
-- |
|
-- |
|
0.40 |
|
4.85 |
|
5.01 |
|
72.91 |
|
12.58% |
|
-57.02% |
|
6.09% |
|
7.53% |
|
$141.98 |
|
$16.76 |
|
$20.68 |
|